Menu
  • Join
  • Login
  • Contact
 

Search abstracts


The safety and efficacy of conversion of brand-name simvastatin(zocor) to generic simvastain (zolotin) in a teaching hospital in taiwan

  • At: 2007 FIP Congress in Beijing (China)
  • Type: Poster
  • By: TSAI, PINE-CHUN (E-Da Hospital, I-Shou University, Kaohsiung, China Taiwan)
  • Co-author(s): Hsiu-Ling, Chang (E-Da Hospital, I-Shou University, KAOHSIUNG, China Taiwan)
    Mei-Fang, Lin (E-Da Hospital, I-Shou University, KAOHSIUNG, China Taiwan)
    Thung-Lip, Lee (E-Da Hospital, I-Shou University, KAOHSIUNG, China Taiwan)
    Chau-Chung, Wu (E-Da Hospital, I-Shou University, KAOHSIUNG, China Taiwan)
  • Abstract:

    Background: Dyslipidemia is well documented to increase the risk of coronary artery

    disease (CAD). The 3-hydroxy -3-methylglutary1 coenzyme A(HMG-CoA) reductase

    inhibitors (statins) are well established to reduce the risk of cardiovascular disease in

    this field. Due to the increasingly high costs of medication in Taiwan, the government

    has set ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses